XTL Biopharmaceuticals Ltd

-

Stock Issuer and Owners

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
XTL Biopharmaceuticals Ltd
TickerXTLB
CIK #0001023549
CUSIP98386D208
SectorLife Sciences - Pharmaceutical Preparations
AddressXtl Biopharmaceuticals Ltd c/o Alston & Bird Llp, 90 Park Avenue, New York, NY 10016
Source [EDGAR]
Reg D Offering (Form D) Filed Raised Terms
XTL Biopharmaceuticals Ltd 2017-03-29 2.8 M Exemption: 506(b) · Duration: One year or less · Revenue: Decline to Disclose
CIK Filing 2011 - 2026
[0001023549] 3
[0001023549] 6-K
[0001023549] D
[0001023549] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
Intracoastal Capital LLC XTL Biopharmaceuticals Ltd [2017-02-27] 0.7
Sabby Management LLC XTL Biopharmaceuticals Ltd [2015-04-02] 4.87
Form 3/4/5 Filer 2011 - 2026
XTL Biopharmaceuticals Ltd
Hillel Fain Osnat
Segal Niv
13F Ownership Over TimeHoldersShares Held
2026-03-31 6 72,702
2025-12-31 6 329,727
2025-09-30 4 226,923
2025-06-30 5 228,496
2025-03-31 5 248,304
2024-12-31 4 228,193
2024-09-30 4 231,858
2024-06-30 5 253,058
2024-03-31 6 337,286
2023-12-31 6 278,984
2023-09-30 5 239,879
2023-06-30 4 240,259
Form 13F Holdings
Firm Period DFND Voting Shares
Gamma Investing LLC [2026-06-30] DFND 1,213 1,213
Prev | Page 1 | Next
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com